{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:58:00Z","timestamp":1774465080277,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.hlc.2018.09.011","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T01:23:54Z","timestamp":1539221034000},"page":"65-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Current Device Therapies for Sudden Cardiac Death Prevention \u2013 the ICD, Subcutaneous ICD and Wearable ICD"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4164-0923","authenticated-orcid":false,"given":"David","family":"Chieng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vince","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Denman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2018.09.011_bib0005","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1161\/CIRCULATIONAHA.110.959734","article-title":"Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks","volume":"123","author":"Goldberger","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.09.011_bib0010","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2018.09.011_bib0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ccep.2017.08.007","article-title":"The subcutaneous defibrillator","volume":"9","author":"Weinstock","year":"2017","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.hlc.2018.09.011_bib0020","unstructured":"Heart Foundation (AU). Sudden Cardiac Death [Internet]. Deakin, ACT (Australia): Heart Foundation (AU); 2018 [cited 2018 Feb 14]. Available from: https:\/\/www.heartfoundation.org.au\/your-heart\/sudden-cardiac-death"},{"key":"10.1016\/j.hlc.2018.09.011_bib0025","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jacc.2015.11.026","article-title":"Safety and efficacy of the subcutaneous implantable defibrillator","volume":"67","author":"Lewis","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2018.09.011_bib0030","author":"Al-Khatib","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2018.09.011_bib0035","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"DANISH investigators. Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2018.09.011_bib0040","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","author":"The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2018.09.011_bib0045","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.CIR.101.11.1297","article-title":"Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone","volume":"101","author":"Connolly","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.09.011_bib0050","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH)","volume":"102","author":"Kuck","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.09.011_bib0055","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1001\/jama.292.23.2874","article-title":"Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials","volume":"292","author":"Desai","year":"2004","journal-title":"JAMA"},{"issue":"November","key":"10.1016\/j.hlc.2018.09.011_bib0060","article-title":"Systematic review for the 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","author":"Kusumoto","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hlc.2018.09.011_bib0065","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Multicenter automatic defibrillator implantation trial II. Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2018.09.011_bib0070","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardia trial investigators","volume":"341","author":"Buxton","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2018.09.011_bib0075","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2018.09.011_bib0080","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Sudden death in heart failure trial (SCD-HeFT). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2018.09.011_bib0085","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJMoa0901889","article-title":"IRIS Investigators. Defibrillator implantation early after myocardial infarction","volume":"361","author":"Steinbeck","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2018.09.011_bib0090","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa041489","article-title":"DINAMIT investigators prophylactic use of an implantable cardioverter\u2013defibrillator after acute myocardial infarction","volume":"351","author":"Hohnloser","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2018.09.011_bib0095","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/CIRCULATIONAHA.108.836791","article-title":"Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"120","author":"Zaman","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.09.011_bib0100","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the cardiomyopathy trial (CAT)","volume":"105","author":"Bansch","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.09.011_bib0105","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","article-title":"AMIOVIRT investigators. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia\u2013AMIOVIRT","volume":"41","author":"Strickberger","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2018.09.011_bib0110","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Defibrillators in non-ischemic cardiomyopathy treatment evaluation (DEFINITE) investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2018.09.011_bib0115","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ccep.2017.08.006","article-title":"Primary prevention implantable cardiac defibrillator trials what have we learned?","volume":"9","author":"Sroubek","year":"2017","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.hlc.2018.09.011_bib0120","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.jacc.2017.01.042","article-title":"French-UK-Sweden CRT network. Adding defibrillation therapy to cardiac resynchronization on the basis of the myocardial substrate","volume":"69","author":"Barra","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"September (FI2)","key":"10.1016\/j.hlc.2018.09.011_bib0125","doi-asserted-by":"crossref","first-page":"f211","DOI":"10.1093\/europace\/eux324","article-title":"Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized clinical trials","volume":"20","author":"Romero","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hlc.2018.09.011_bib0130","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/jce.13284","article-title":"Sudden cardiac death in nonischemic cardiomyopathy: refining risk assessment","volume":"28","author":"Zipse","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hlc.2018.09.011_bib0135","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1540-8159.2009.02362.x","article-title":"Defibrillators in nonischemic cardiomyopathy treatment evaluation (DEFINITE) investigators. Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy","volume":"32","author":"Daubert","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hlc.2018.09.011_bib0140","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/CIRCEP.113.000216","article-title":"Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation","volume":"6","author":"Gatzoulis","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hlc.2018.09.011_bib0145","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4330\/wjc.v7.i6.344","article-title":"Utility of electrophysiological studies to predict arrhythmic events","volume":"7","author":"Hilfiker","year":"2015","journal-title":"World J Cardiol"},{"key":"10.1016\/j.hlc.2018.09.011_bib0150","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.tcm.2017.06.003","article-title":"Arrhythmic risk stratification in non-ischemic dilated cardiomyopathy: where do we stand after DANISH?","volume":"27","author":"Dilaveris","year":"2017","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.hlc.2018.09.011_bib0155","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2018.09.011_bib0160","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"Cardiac resynchronization-heart failure (CARE-HF) study investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"issue":"November (11)","key":"10.1016\/j.hlc.2018.09.011_bib0165","article-title":"Importance of implantable cardioverter-defibrillator back-up in cardiac resynchronization therapy recipients: a systematic review and meta-analysis","volume":"4","author":"Barra","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hlc.2018.09.011_bib0170","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jacc.2017.01.044","article-title":"Should nonischemic CRT candidates receive CRT-P or CRT-D?","volume":"69","author":"Levy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2018.09.011_bib0175","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jacc.2015.05.057","article-title":"Changes in follow-up left ventricular ejection fraction associated with outcomes in primary prevention implantable cardioverter-defibrillator and cardiac resynchronization therapy device recipients","volume":"66","author":"Zhang","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2018.09.011_bib0180","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jacc.2017.07.712","article-title":"Outcomes of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy","volume":"70","author":"Leyva","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2018.09.011_bib0185","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.hrthm.2015.06.039","article-title":"A novel method to predict the proportional risk of sudden cardiac death in heart failure: derivation of the seattle proportional risk model","volume":"12","author":"Shadman","year":"2015","journal-title":"Heart Rhythm"},{"issue":"July (7)","key":"10.1016\/j.hlc.2018.09.011_bib0190","article-title":"Sudden cardiac death substrate imaged by magnetic resonance imaging: from investigational tool to clinical application","volume":"10","author":"Wu","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hlc.2018.09.011_bib0195","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","article-title":"Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction","volume":"135","author":"Halliday","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.09.011_bib0200","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/CIRCIMAGING.113.001144","article-title":"Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"7","author":"Kuruvilla","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hlc.2018.09.011_bib0205","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","article-title":"Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Marco","year":"2017","journal-title":"JACC Heart Fail"},{"issue":"July (4)","key":"10.1016\/j.hlc.2018.09.011_bib0210","article-title":"Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): Study protocol for a randomized controlled trial","volume":"22","author":"Selvanayagam","year":"2017","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hlc.2018.09.011_bib0215","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jcmg.2017.04.021","article-title":"Scar characterization to predict life-threatening arrhythmic events and sudden cardiac death in patientswith cardiac resynchronization therapy the GAUDI-CRT study","volume":"11","author":"Acosta","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hlc.2018.09.011_bib0220","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcmg.2015.12.001","article-title":"International T1 multicentre CMR. Outcome study. T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure","volume":"9","author":"Puntmann","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hlc.2018.09.011_bib0225","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.hrthm.2014.12.020","article-title":"Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators","volume":"12","author":"Chen","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hlc.2018.09.011_bib0230","first-page":"e783","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.09.011_bib0235","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis andmanagement of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hlc.2018.09.011_bib0240","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis: a systematic review and meta-analysis","volume":"10","author":"Coleman","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"January (1)","key":"10.1016\/j.hlc.2018.09.011_bib0245","article-title":"Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance","volume":"9","author":"Murtagh","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hlc.2018.09.011_bib0250","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","article-title":"Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator","volume":"128","author":"Weiss","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.09.011_bib0255","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/CIRCULATIONAHA.116.021889","article-title":"Defibrillators: selecting the right device for the right patient","volume":"134","author":"Al-Khatib","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.09.011_bib0260","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.jacc.2015.02.047","article-title":"Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry","volume":"65","author":"Burke","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2018.09.011_bib0265","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.hrthm.2015.09.010","article-title":"Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications","volume":"13","author":"Olde Nordkamp","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hlc.2018.09.011_bib0270","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ahj.2012.02.012","article-title":"Rationale and design of the PRAETORIAN trial: a prospective, randomized comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy","volume":"163","author":"Olde Nordkamp","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.hlc.2018.09.011_bib0275","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa0909545","article-title":"An entirely subcutaneous implantable cardioverter-defibrillator","volume":"363","author":"Bardy","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2018.09.011_bib0280","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/eurheartj\/ehu112","article-title":"EFFORTLESS investigators worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry","volume":"35","author":"Lambiase","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2018.09.011_bib0285","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/heartjnl-2016-310852","article-title":"Efficacy and safety of the subcutaneous implantable cardioverter defibrillator: a systematic review","volume":"103","author":"Chue","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.hlc.2018.09.011_bib0290","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.hrthm.2014.04.012","article-title":"Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator","volume":"11","author":"Gold","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hlc.2018.09.011_bib0295","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1540-8167.2011.02199.x","article-title":"Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study","volume":"23","author":"Gold","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hlc.2018.09.011_bib0300","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijcard.2015.05.135","article-title":"Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management","volume":"195","author":"Nordkamp","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2018.09.011_bib0305","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ihj.2015.01.001","article-title":"Inappropriate shock for myopotential over-sensing in a patient with subcutaneous ICD","volume":"67","author":"Corzani","year":"2015","journal-title":"Indian Heart J"},{"key":"10.1016\/j.hlc.2018.09.011_bib0310","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1161\/CIR.0000000000000394","volume":"133","author":"Piccini","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.09.011_bib0315","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.jacc.2017.07.778","article-title":"Defibrillation for ventricular fibrillation: a shocking update","volume":"70","author":"Nichol","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2018.09.011_bib0320","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1540-8159.2004.00378.x","article-title":"WEARIT investigators and coordinators; BIROAD investigators and coordinators. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT\/BIROAD","volume":"27","author":"Feldman","year":"2004","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hlc.2018.09.011_bib0325","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/CIRCULATIONAHA.115.015677","article-title":"Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II Registry)","volume":"132","author":"Kutyifa","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.09.011_bib0330","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jacc.2010.04.016","article-title":"Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival","volume":"56","author":"Chung","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2018.09.011_bib0335","unstructured":"Olgin. J. Vest Prevention of Early Sudden Death Trial \u2013 VEST. American College of Cardiology Annual Scientific Session. Orlando, Florida, 2018."},{"key":"10.1016\/j.hlc.2018.09.011_bib0340","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/CIRCULATIONAHA.116.024287","article-title":"Editorial. The wearable cardioverter\u2013defibrillator: is it now the standard of care?","volume":"134","author":"Lee","year":"2016","journal-title":"Circulation"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950618319206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950618319206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:00:58Z","timestamp":1761415258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950618319206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1443950618319206"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2018.09.011","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Device Therapies for Sudden Cardiac Death Prevention \u2013 the ICD, Subcutaneous ICD and Wearable ICD","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2018.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}